Home › Leiomyosarcoma › Massachusetts › Boston

Leiomyosarcoma clinical trials in Boston, MA

5 studies for Leiomyosarcoma are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

RecruitingPhase 1

Dana-Farber Cancer Institute, Boston

Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT05711615

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

RecruitingPhase 1/2

Dana Farber Cancer Institute, Boston

Ages 18 and older · All sexes · Updated Oct 22, 2026 · NCT06975293

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

RecruitingPhase 3

Dana-Farber/Harvard Cancer Center, Boston

Ages 18 and older · All sexes · Updated Oct 7, 2026 · NCT04031677

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

RecruitingPhase 1/2

Dana Farber Cancer Institute, Boston

Up to age 30 · All sexes · Updated Aug 3, 2026 · NCT06239272

Metastatic Leiomyosarcoma Biomarker Protocol

RecruitingObservational study

Dana- Farber, Boston

All ages · All sexes · Updated Jun 24, 2026 · NCT05653388

Leiomyosarcoma trials in other cities

Other studies in Boston

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.